in a study of nearly 20,000 people posted to the online server medrxiv on july 17, the vast majority with mild-to-moderate covid-19 made plentiful antibodies.
in a study of nearly 20,000 people posted to the online server medrxiv on july 17, the vast majority with mild-to-moderate covid-19 made plentiful antibodies.